Browse Pet Safety Reports
969,382 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 969,382 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 969,382 FDA veterinary adverse event reports for Dog.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Jan 15, 2026 | Dog | Poodle (unspecified), Terri... | Imidacloprid; Moxidectin | Lethargy (see also Central nervous system depression in Neurological); Hard s... | Ongoing |
| Jan 15, 2026 | Dog | Schnauzer (unspecified), Po... | Pyrantel Pamoate;Sarolaner | Seizure NOS; Intentional misuse | Outcome Unknown |
| Jan 15, 2026 | Dog | Dog (unknown) | Ilunocitinib | Neutropenia | Recovered/Normal |
| Jan 15, 2026 | Dog | Crossbred Canine/dog, Havanese | Fluralaner Powder For Inj Susp | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Jan 15, 2026 | Dog | Shepherd Dog - German | Milbemycin Oxime; Praziquantel | Lack of efficacy (endoparasite) - hookworm; Diarrhoea | Ongoing |
| Jan 15, 2026 | Dog | Shepherd Dog - German, Dog ... | Ilunocitinib | Hypoalbuminaemia | Ongoing |
| Jan 14, 2026 | Dog | Cattle Dog - Australian (bl... | Milbemycin Oxime | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Jan 14, 2026 | Dog | Rottweiler | Bedinvetmab | Musculoskeletal disorder NOS; Collapse NOS (see also Cardio-vascular and Neur... | Died |
| Jan 14, 2026 | Dog | Terrier - Norfolk | Grapiprant | Weight gain | Outcome Unknown |
| Jan 14, 2026 | Dog | Chihuahua | Afoxolaner | Injection site pain | Recovered/Normal |
| Jan 14, 2026 | Dog | Shepherd Dog - German, Dog ... | Grapiprant | Emesis (multiple); Reluctant to move; Unable to rise; Difficulty to rise; Wea... | Ongoing |
| Jan 13, 2026 | Dog | Boxer (German Boxer) | Milbemycin Oxime | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Jan 13, 2026 | Dog | American Pit Bull Terrier | Grapiprant | Trembling; Panting; Medication error NOS | Recovered/Normal |
| Jan 13, 2026 | Dog | Cattle Dog - Australian (bl... | Moxidectin | Stumbling gait; Quiet; Vocalisation; Decreased activity | Ongoing |
| Jan 13, 2026 | Dog | Cattle Dog - Australian (bl... | Fluralaner Powder For Inj Susp | Lethargy (see also Central nervous system depression in Neurological); Reluct... | Ongoing |
| Jan 13, 2026 | Dog | Shepherd Dog (unspecified),... | Deracoxib | Dehiscence; Intestinal perforation; Pleural effusion; Peritonitis; Death by e... | Euthanized |
| Jan 12, 2026 | Dog | Hound (unspecified), Dog (u... | Milbemycin Oxime | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Jan 12, 2026 | Dog | Terrier - Yorkshire | Fluralaner Powder For Inj Susp | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Jan 12, 2026 | Dog | Retriever - Labrador | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - tick NOS | Ongoing |
| Jan 12, 2026 | Dog | Retriever - Golden | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Anaplasma; Intentional misuse | Ongoing |
| Jan 12, 2026 | Dog | Hound (unspecified), Dog (u... | Oclacitinib Maleate | Anxiety; Hiding; Medication error NOS | Ongoing |
| Jan 12, 2026 | Dog | Dog (unknown) | Lotilaner,Moxidectin,Praziquantel,Pyr... | Seizure NOS | Recovered/Normal |
| Jan 12, 2026 | Dog | Shepherd Dog - Australian | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - tick NOS | Ongoing |
| Jan 12, 2026 | Dog | Shepherd Dog - German | Estriol | Swelling NOS; Lameness; Bone and joint disorder NOS; Abnormal radiograph finding | Ongoing |
| Jan 12, 2026 | Dog | Chihuahua | Afoxolaner 9.375Mg / Moxidectin 45Mcg... | Vomiting; Diarrhoea; Itching | Recovered/Normal |
| Jan 12, 2026 | Dog | Bulldog - French | Milbemycin Oxime; Praziquantel | Lack of efficacy (endoparasite) - hookworm | Outcome Unknown |
| Jan 12, 2026 | Dog | Shar Pei | Oclacitinib Maleate | Fever; Swollen limb | Ongoing |
| Jan 12, 2026 | Dog | Chihuahua | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Jan 11, 2026 | Dog | Dachshund - Miniature | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - roundworm NOS; Increased drinking | Outcome Unknown |
| Jan 11, 2026 | Dog | Catahoula Leopard Dog | Ilunocitinib | Hind limb paresis; Intentional misuse | Ongoing |
| Jan 11, 2026 | Dog | Poodle (unspecified) | Insulin Injectable Vial | Tremor; Head bobbing; Head tilt - neurological disorder (see also Head tilt -... | Ongoing |
| Jan 8, 2026 | Dog | Shepherd Dog - German | Fluralaner 13.64% 12-Week Chew | Limping | Recovered/Normal |
| Jan 8, 2026 | Dog | Lhasa Apso | Ilunocitinib | Injection site mass NOS; Injection site inflammation; Abnormal cytology | Ongoing |
| Jan 8, 2026 | Dog | Retriever - Labrador | Milbemycin Oxime; Praziquantel | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Jan 8, 2026 | Dog | Terrier (unspecified), Dog ... | Moxidectin | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Jan 8, 2026 | Dog | Great Pyrenees, Shepherd (u... | Ilunocitinib | Skin lesion NOS; Skin inflammation NOS; Skin ulcer; Crust; Bacterial skin inf... | Ongoing |
| Jan 8, 2026 | Dog | Corgi (unspecified) | Milbemycin Oxime,Praziquantel Micronized | Lack of efficacy (bacteria) - Ehrlichia | Outcome Unknown |
| Jan 7, 2026 | Dog | Spaniel - Springer English,... | Isoflurane | Diarrhoea; Anorexia; Haemorrhagic diarrhoea; Quiet; Pale mucous membrane; Abd... | Died |
| Jan 7, 2026 | Dog | Mountain Cur | Moxidectin | Lack of efficacy (endoparasite) - heartworm; Medication error NOS | Ongoing |
| Jan 7, 2026 | Dog | Shepherd Dog - Australian | Afoxolaner 75Mg / Moxidectin 360Mcg /... | Vomiting | Outcome Unknown |
| Jan 6, 2026 | Dog | Bulldog - French | Entyce | Lethargy (see also Central nervous system depression in Neurological); Decrea... | Ongoing |
| Jan 6, 2026 | Dog | Beagle | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Jan 6, 2026 | Dog | Schnauzer - Miniature | Milbemycin Oxime | Ataxia; Collapse of leg; Elevated blood urea nitrogen (BUN); Elevated cholest... | Ongoing |
| Jan 5, 2026 | Dog | Retriever - Golden, Poodle ... | Afoxolaner | Vomiting; Lethargy (see also Central nervous system depression in Neurologica... | Recovered/Normal |
| Jan 5, 2026 | Dog | Shepherd Dog - German | Afoxolaner | Emesis; Increased packed cell volume (PCV); Not himself/herself; Elevated hae... | Outcome Unknown |
| Jan 5, 2026 | Dog | Bulldog - English | Milbemycin/Lufenuron/Pzq Chew | Lack of efficacy (endoparasite) - tapeworm | Ongoing |
| Jan 5, 2026 | Dog | Bulldog - English | Ilunocitinib | Head tremor; Fly biting behaviour; Lack of efficacy - NOS; Polydipsia; Prurit... | Outcome Unknown |
| Jan 3, 2026 | Dog | Retriever - Labrador, Dog (... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Jan 3, 2026 | Dog | Cattle Dog - Australian (bl... | Pyrantel Pamoate;Sarolaner | Grand mal seizure; Lateral recumbency; Shaking; Hyperproteinaemia; Elevated h... | Ongoing |
| Jan 3, 2026 | Dog | Rottweiler | Grapiprant | Ataxia | Recovered/Normal |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.